Stevanato Group (STVN US)

Analysis

Health Care • Italy

Stevanato Group is a global provider of integrated solutions for drug containment, drug delivery, and diagnostics to the pharmaceutical, biotechnology, and life sciences industries. The company offers a portfolio of products and services, including glass primary packaging (syringes, vials, cartridges), plastic components, drug delivery systems (pen and auto-injectors), and specialized machinery for pharmaceutical manufacturing. Stevanato Group is headquartered in Piombino Dese, Italy, and was founded in 1949.

Refresh

Exchange Announcement • 21 May 2024 04:37

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Exchange Announcement • 26 Mar 2024 04:04

424B5 | Prospectus

Exchange Announcement • 21 Mar 2024 05:16

424B5 | Prospectus

Exchange Announcement • 22 Jan 2024 23:22

US SEC Form SC 13G for Stevanato Group S.p.A.

Exchange Announcement • 05 Jan 2024 23:20

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

424B5 | Prospectus

424B5 | Prospectus

US SEC Form SC 13G for Stevanato Group S.p.A.

US SEC Form SC 13G/A for Stevanato Group S.p.A.